Literature DB >> 23543035

The use of procalcitonin as a marker of sepsis in children.

Bin Mathew1, Dinesh Roy D, T Vijaya Kumar.   

Abstract

OBJECTIVE: Sepsis is a life-threatening disease which is associated with high rates of morbidity and mortality. The critically ill patients often manifest a Systemic Inflammatory Response Syndrome (SIRS) which is independent of an infection. The early diagnosis of different severities of sepsis is important for an early implementation of the specific therapies. Our objective was to evaluate the diagnostic and the prognostic values of blood Procalcitonin (PCT) in cases of bacterial septicaemia in children.
METHODS: The total sample comprised of 150 subjects who were admitted to the ICU with septicaemia and 50 normal, healthy, age and sex matched children. The first sample was collected at the time of admission, before the start of the antibiotic therapy (T0). A second sample was collected at 24 hours (T24) and a final sample was collected at 96 hours (T96). A PCT value of > 0.5ng/ml was accepted as positive.
RESULTS: 63% of the children who were diagnosed with a bacterial aetiology showed detectable blood PCT levels with higher concentrations, while in the children who were diagnosed with a viral aetiology, only 22.2 % had detectable PCT levels, but in lower concentrations. The mean percentage reduction in the PCT value among the bacterial infection subjects was 44.39 ± 41.82 as compared to that in the viral infection subjects (5.71 ± 26.68) and in the subjects where the aetiology was not established (5.71 ± 26.68).
CONCLUSION: The results which were obtained in our study con- firmed that the PCT levels were a better marker for the bacterial infections. The PCT measurements may be used as a guide to the antibiotic therapy in critically ill children with suspected sepsis.

Entities:  

Keywords:  Bacterial infection; Procalcitonin; SIRS; Sepsis

Year:  2013        PMID: 23543035      PMCID: PMC3592298          DOI: 10.7860/JCDR/2013/4739.2753

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  10 in total

1.  Burden of morbidities and the unmet need for health care in rural neonates--a prospective observational study in Gadchiroli, India.

Authors:  A T Bang; R A Bang; S Baitule; M Deshmukh; M H Reddy
Journal:  Indian Pediatr       Date:  2001-09       Impact factor: 1.411

Review 2.  Pathobiochemistry and clinical use of procalcitonin.

Authors:  Michael Meisner
Journal:  Clin Chim Acta       Date:  2002-09       Impact factor: 3.786

Review 3.  Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Petros Kopterides; Ilias I Siempos; Iraklis Tsangaris; Argirios Tsantes; Apostolos Armaganidis
Journal:  Crit Care Med       Date:  2010-11       Impact factor: 7.598

4.  Rapid identification of bacterial pathogens in positive blood culture bottles by use of a broad-based PCR assay coupled with high-resolution melt analysis.

Authors:  Helen Won; Richard Rothman; Padmini Ramachandran; Yu-Hsiang Hsieh; Aleksandar Kecojevic; Karen C Carroll; Deborah Aird; Charlotte Gaydos; Samuel Yang
Journal:  J Clin Microbiol       Date:  2010-07-14       Impact factor: 5.948

5.  Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.

Authors:  Kevin W Garey; Milind Rege; Manjunath P Pai; Dana E Mingo; Katie J Suda; Robin S Turpin; David T Bearden
Journal:  Clin Infect Dis       Date:  2006-05-16       Impact factor: 9.079

6.  Procalcitonin and C-reactive protein levels in neonatal infections.

Authors:  G Monneret; J M Labaune; C Isaac; F Bienvenu; G Putet; J Bienvenu
Journal:  Acta Paediatr       Date:  1997-02       Impact factor: 2.299

Review 7.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

Review 8.  [Procalcitonin, a new marker for bacterial infections].

Authors:  F Ferrière
Journal:  Ann Biol Clin (Paris)       Date:  2000 Jan-Feb       Impact factor: 0.459

9.  Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children.

Authors:  Corsino Rey; Marta Los Arcos; Andrés Concha; Alberto Medina; Soledad Prieto; Pablo Martinez; Belen Prieto
Journal:  Intensive Care Med       Date:  2007-01-27       Impact factor: 17.440

Review 10.  [The diagnostic value of procalcitonin in severe sepsis].

Authors:  Judita Andrejaitiene
Journal:  Medicina (Kaunas)       Date:  2006       Impact factor: 2.430

  10 in total
  4 in total

1.  Clinical and Cost-Effectiveness of Procalcitonin Test for Prodromal Meningococcal Disease-A Meta-Analysis.

Authors:  Jennifer M Bell; Michael D Shields; Ashley Agus; Kathryn Dunlop; Thomas Bourke; Frank Kee; Fiona Lynn
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

Review 2.  Update on procalcitonin measurements.

Authors:  Michael Meisner
Journal:  Ann Lab Med       Date:  2014-06-19       Impact factor: 3.464

3.  Use of common blood parameters for the differential diagnosis of childhood infections.

Authors:  Weiying Wang; Shu Hua Li
Journal:  PLoS One       Date:  2022-09-12       Impact factor: 3.752

4.  Correlation of Procalcitonin and C-Reactive Protein with Intra-Abdominal Hypertension in Intra-Abdominal Infections: Their Predictive Role in the Progress of the Disease.

Authors:  Bedri Braha; Dafina Mahmutaj; Mehmet Maxhuni; Burim Neziri; Shaip Krasniqi
Journal:  Open Access Maced J Med Sci       Date:  2018-03-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.